CoChat

The effectiveness of digital health intervention on glycemic control and physical activity in patients with type 2 diabetes: a systematic review and meta-analysis

Open access
Xue, Haoyuan, Zhang, Lin, Shi, Yarong, Zhang, Hao, Zhang, Chuanrong, Liu, Yang, Tan, Wenshu, Liu, Yaorong · 2025 · Frontiers in Digital Health

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 28 of the 43 sources its claims cite were checked for support.

Abstract

Introduction: Digital health interventions (DHIs) offer promising strategies for managing type 2 diabetes mellitus (T2DM), yet their efficacy on physical activity remains inconsistent. This systematic review and meta-analysis evaluates DHIs' effectiveness across key clinical endpoints. Methods: Following PRISMA guidelines and PROSPERO registration (CRD420251032375), five databases (Web of Science, Embase, Scopus, Cochrane, PubMed) were searched through February 2025. Randomized controlled trials (RCTs) assessing DHIs (mobile applications, phone calls or SMS, online platforms, remote monitoring) versus usual care in T2DM patients were included. Primary outcomes were HbA1c, fasting blood glucose (FBG), postprandial blood glucose (PBG), HOMA-IR, and physical activity. Risk of bias was evaluated using Cochrane RoB 2. Meta-analyses employed random/fixed-effect models in Review Manager 5.3, with subgroup and sensitivity analyses for heterogeneity (I ² > 50%). Results: From 9,499 records, 118 RCTs (21,662 participants) were analyzed. DHIs significantly reduced HbA1c (MD = −0.32% to −0.54%), FBG (MD = −0.30 to −0.85), and PBG (SMD = −0.58) versus controls (p < 0.05). Subgroup analyses indicated online platforms most effectively lowered HbA1c (MD = −0.54). No improvements occurred in HOMA-IR (MD = −0.18, 95% CI: −0.79 to 0.44) or physical activity (SMD = 0.16, 95% CI: −0.08 to 0.39). Cost analyses revealed lower expenses in DHI groups (mean: $269.31 vs. $465.37). High heterogeneity (I ² = 69–92%) was observed for glycemic outcomes, partially explained by intervention duration and sample size in meta-regression. Discussion: DHIs demonstrate robust efficacy for glycemic management in T2DM, particularly through online platforms and remote monitoring. However, they fail to enhance physical activity or insulin resistance. Future studies should prioritize adaptive designs for sustained behavioral change and investigate long-term cost-effectiveness. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251032375, identifier (CRD420251032375).

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of 118 RCTs (21,662 adults with T2DM) found digital health interventions significantly improved HbA1c, fasting blood glucose, and postprandial blood glucose versus controls, but not HOMA-IR or physical activity. Online platforms produced the largest HbA1c reduction, and DHI groups had lower mean costs, though heterogeneity was high.

Key findings

  • From 9,499 records, 118 RCTs (21,662 participants) were analyzed. DHIs reduced HbA1c: online platform MD = −0.54 (95% CI −0.71 to −0.37, I² = 80%), remote monitoring MD = −0.32 (95% CI −0.41 to −0.22, I² = 86%), mobile applications MD = −0.29 (95% CI −0.40 to −0.17, I² = 69%), and phone calls or SMS MD = −0.31 (95% CI −0.51 to −0.11, I² = 77%).
  • FBG was lowered by phone calls or SMS (MD = −0.85, 95% CI −1.40 to −0.30, I² = 0%), online platforms (MD = −0.82, 95% CI −1.10 to −0.54, I² = 0%), mobile applications (MD = −0.68, 95% CI −1.17 to −0.20, I² = 76%), and remote monitoring (MD = −0.39, 95% CI −0.56 to −0.21, I² = 53%). PBG improved overall (SMD = −0.58, 95% CI −0.80 to −0.35, I² = 76%).
  • No significant improvement was found for HOMA-IR (MD = −0.18, 95% CI −0.79 to 0.44, I² = 89%) or physical activity (SMD = 0.16, 95% CI −0.08 to 0.39, I² = 71%). Cost analyses from 9 studies showed lower mean costs in DHI groups ($269.31) than controls ($465.37).
  • High heterogeneity (I² = 69–92%) was observed for glycemic outcomes; meta-regression suggested sample size influenced remote monitoring HbA1c findings (p = 0.008), and intervention duration and sample size partially explained heterogeneity.

Methods

  • PRISMA-guided systematic review and meta-analysis, prospectively registered in PROSPERO (CRD420251032375). Five databases (Web of Science, Embase, Scopus, Cochrane Library, PubMed) were searched through February 17, 2025. Included RCTs assessed DHIs (mobile applications, phone calls or SMS, online platforms, remote monitoring) versus usual care/no intervention/conventional treatment in T2DM patients, with outcomes including HbA1c, FBG, PBG, HOMA-IR, and physical activity.
  • Two independent investigators screened and extracted data; risk of bias was assessed with Cochrane RoB 2 and evidence quality with GRADE. Meta-analyses used Review Manager 5.3 with fixed-effect models for I² < 50% and random-effects models for I² ≥ 50%, plus subgroup, leave-one-out sensitivity, and random-effects meta-regression analyses in Stata 16.0 for research year, duration, intervention frequency, and sample size.
  • The analysis included 118 RCTs and 21,662 adults with T2DM; HbA1c was measured in 114 studies, FBG in 41, PBG in 12, HOMA-IR in 4, physical activity in 11, and cost outcomes in 9. Included studies were published between 2004 and 2024.

Limitations

  • The paper states that including only English-language articles may introduce language bias; statistical power for HOMA-IR and physical activity was constrained by limited studies; many trials had high risk of bias or inadequate allocation concealment; and predominantly short-term follow-up (≤12 months) leaves long-term sustainability uncertain.
  • Evident from the text: heterogeneity remained high for glycemic outcomes (I² = 69–92%) and was only partially explained by subgroup and meta-regression analyses; cost conclusions rest on only 9 studies, with one showing higher experimental-group costs; physical activity evidence comes from 11 studies, and none of the four DHI modalities significantly promoted physical activity.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fdgth.2025.1630588

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flow diagram.
Figure 1 PRISMA flow diagram.CC BY · PubMed Central
Figure 2 The effect of remote monitoring (a) and online platform (b) on HbA1c.
Figure 2 The effect of remote monitoring (a) and online platform (b) on HbA1c.CC BY · PubMed Central
Figure 3 The effect of phone calls or SMS (a) and mobile application (b) on HbA1c.
Figure 3 The effect of phone calls or SMS (a) and mobile application (b) on HbA1c.CC BY · PubMed Central
Figure 4 The effect of DHIs on FBG. (a) Mobile application; (b) remote monitoring; (c) online platform; (d) phone call or SMS.
Figure 4 The effect of DHIs on FBG. (a) Mobile application; (b) remote monitoring; (c) online platform; (d) phone call or SMS.CC BY · PubMed Central
Figure 5 The effect of DHIs on HOMA-IR.
Figure 5 The effect of DHIs on HOMA-IR.CC BY · PubMed Central
Figure 6 The effect of DHIs on PBG.
Figure 6 The effect of DHIs on PBG.CC BY · PubMed Central
Figure 7 The effect of DHIs on physical activity.
Figure 7 The effect of DHIs on physical activity.CC BY · PubMed Central

Verification

Claims the paper makes

22 Valid · 2 Not valid · 9 Not checked · 78 Own results and interpretations

63 more claims · 6 with their cited sources checked

Create a free account to see all 111 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 32
  • It may state two separate claims as one. 15
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 52 references

Cited by

See all 15

Metadata

Authors
Xue, H., Zhang, L., Shi, Y., Zhang, H., Zhang, C., Liu, Y., Tan, W., & Liu, Y.
Affiliations
  • Xi'an Physical Education University (CN)
  • Communication University of Shanxi (CN)
Corresponding author
Liu, Yaorong
Venue
Frontiers in Digital Health
Published
2025-07-29
Volume
7
Pages
1630588-1630588
ISSN
2673-253X (ISSN-L)
OpenAlex
W4412896178
Cited by
15
References
52
Citations by year
2026: 14 · 2025: 1
FWCI
2.95
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Digital Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
digital health interventions, type 2 diabetes, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, insulin resistance, physical activity, mobile health apps, digital platforms, remote monitoring, cost-effectiveness, behavior change, usual care comparison

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effectiveness of digital health intervention on glycemic control and physical activity in patients with type 2 diabetes: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fdgth.2025.1630588
The paper
Xue, H., Zhang, L., Shi, Y., Zhang, H., Zhang, C., Liu, Y., Tan, W., & Liu, Y. (2025). The effectiveness of digital health intervention on glycemic control and physical activity in patients with type 2 diabetes: a systematic review and meta-analysis. Frontiers in Digital Health. https://doi.org/10.3389/fdgth.2025.1630588

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.